RTP company lands work with AstraZeneca

Research Triangle Park-based G1 Therapeutics (Nasdaq: GTHX) – which raised more than $108 million in its initial public offering earlier this year – has landed work with global biopharmaceutical behemoth AstraZeneca. G1 will collaborate with AstraZeneca on a new clinical trial evaluating AstraZeneca’s drug Tagrisso in combination with G1’s drug cand idate G1T38 for the treatment of a type of non-small cell lung cancer.  According to G1, it “will sponsor and conduct the Phase 1b/2 study…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news